Cell-mediated immunity is an important aspect of host resistance against Cryptococcus neoformans. Using a CBA/J murine model, we demonstrated that injection of cryptococcal antigen (CneF) at dosages sufficient to stimulate the antigenemia observed in cryptococcosis patients induces specific T-cell-mediated Cryptococcosis is a disease caused by an encapsulated yeastlike organism, Cryptococcus neoformans. It is well established that patients with disseminated cryptococcosis have detectable levels of cryptococcal antigen in their body fluids (4, 6, 9, 10, 12, 23, 25, 26) , and high or increasing antigen titers are associated with progressive disease (4). Furthermore, it is not unusual to find individuals with active cryptococcosis displaying depressed cell-mediated responses to cryptococcal antigens (3, 11). Investigations with a murine cryptococcosis model demonstrated that mice with high numbers of cryptococci in their tissues have high cryptococcal antigen titers which in turn correlate with depressed delayed hypersensitivity (DTH) responses (14). Those results, together with the observations made in human cryptococcosis, stimulated us to propose that high levels of cryptococcal antigen might be down regulating the cryptococcal cell-mediated immune response, an important resistance mechanism against C. neoformans (13). In more recent studies in our laboratory it was demonstrated that cryptococcal antigen injected intravenously (i.v.) will trigger the induction of a series of suppressor cells and factors which specifically suppress cell-mediated immune responses to cryptococcal antigen (20) (21) (22) . Briefly, the order of the induction of the suppressive elements and their functional and phenotypic characteristics are as follows. When cryptococcal antigen is injected i.v. into mice at levels simulating antigen titers in patients with systemic cryptococcosis, firstorder suppressor (Tsl) cells are induced from cyclophosphamide-sensitive precursors and are found in the lymph nodes (LN) (20). Phenotypically, Tsl cells are Lyt 1+ 2-,
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MATERIALS AND METHODS
Mice. Inbred CBA/J (H-2k, Lyt 1.1, Lyt 2.1) female mice, 7 to 10 weeks of age, purchased from the Jackson Laboratory, Bar Harbor, Maine, were used in these studies.
Cryptococcal antigen. A cryptococcal culture filtrate (CneF) antigen was used for induction of suppression, immunization, and footpad challenge. It was prepared by the method of Cauley and Murphy (2) . The lot of CneF antigen used in these studies had a protein concentration of 4.1 mg/ml, determined by the procedure of Lowry et al. (15) ies, complement, and cell treatment procedures used in these experiments were previously described (20, 22) .
Induction and elicitation of DTH to C. neoformans. DTH was induced as described previously (20) . Briefly, mice were inoculated at each of two sties at the base of the tail with 0.1 ml of an emulsion of CneF antigen in complete Freund adjuvant (CneF-CFA), and 6 days later the footpads of animals were challenged with 30 RI of CneF antigen as described by Cauley and Murphy (2) . Final measurements of the footpads were made 24 h after challenge. Immune or positive and naive or negative DTH controls were included in each experiment. Previous data indicated that naive mice had similar levels of footpad responses to CneF antigen as did mice injected 6 days earlier with physiological saline-CFA (22) ; therefore, naive animals were used as negative controls in subsequent experiments.
Induction of cryptococcal Tsl cells. Mice were injected i.v. with 0.3 ml of CneF antigen 7 days before collecting peripheral and mesenteric LN cells. Single cell suspensions were made and served as the source of Tsl cells (20) .
Induction of cryptococcal Ts2 cells. Tsl cells were injected i.v. into syngeneic mice, and 7 days later spleens of the recipient mice were collected as the source of Ts2 cells (22) .
Kinetics of Tsl function. To determine when Tsl cells had to be adoptively transferred in relationship to the time of immunization to effectively suppress the DTH response, mice were injected i.v. with 5 x 107 Tsl cells the day before, the day of, or 1 to 7 days after immunization, and then their footpads were challenged with CneF antigen 4 (20) . Therefore, the first experimental approach was as follows.
Mice were immunized on day 0. Tsl cells were adoptively transferred on days -1, 0, or 1 through 7. Four days after Tsl cell transfer, the footpads of mice were tested, and footpad thicknesses were measured 24 h later. The results of one of three such experiments are shown in Fig. 1 . Tsl cells suppressed the DTH response only when they were transferred the day before, the day of, or the day after immunization. The percentages of suppression achieved at those time periods were 50, 67, and 42, respectively, whereas, no suppression was observed when Tsl cells were transferred 2 or more days after immunization.
Transfer of TDH cells from immunized or immunized and suppressed mice. The second approach in these studies was to determine whether TDH cells were present in mice which had been tolerized with CneF antigen before immunization or which had been given 5 x 107 Tsl cells at the time of immunization. To assess the presence of TDH cells, spleen and LN cells were collected 6 days after immunization from the two groups of mice, i.e., immunized and tolerized-immunized groups, and adoptively transferred to separate groups of naive syngeneic recipients. The footpads of the recipient mice were immediately tested with CneF antigen, and 24 h later the final measurements of the footpads were made. Since there was a possibility that Ts2 cells could have been induced in the donors of TDH cells by either the tolerizing dose of CneF antigen or Tsl cells, portions of the spleen and LN cell populations collected from those animals were treated with anti-Lyt 2.1 antibody and complement to eliminate Ts2 cells before cell transfer. The results of adoptively transferring putative TDH cells from either immunized mice or mice tolerized with cryptococcal antigen 7 days before immunization are shown (Fig. 2) . Figure 3 presents the results obtained from similar adoptive transfer experiments in which suppression was achieved with cryptococcal Tsl cells given at the time of immunization. It is apparent that DTH could be transferred with either LN or spleen cells from immunized mice (Fig. 2 and 3 , groups 6 and 7, respectively). However, neither LN nor spleen cells from mice tolerized with cryptococcal antigen or Tsl cells transferred significant responses ( Fig. 2 and 3 , groups 2 and 3, respectively). Furthermore, the responses in the suppressed groups (groups 2 and 3) could not be restored when any Ts2 cells that might be present were removed by treatment with anti-Lyt 2 antibody and complement ( Fig. 2 and 3 , groups 4 and 5, respectively). When the footpads of groups 8 and 9 ( Fig. 2 and 3) were tested, the results were not significantly different from those obtained from the respective untreated immune groups (Fig. 2 and 3 , groups 6 and 7), demonstrating that treatment with anti-Lyt 2.1 and complement did not affect the TDH cells.
Since the possibility existed that treatment with anti-Lyt 2 and complement could be lysing Ts2 cells and releasing TsF2, a soluble factor which will suppress TDH cells (21) , an additional study was done to establish that under the conditions used, released TsF2 was not effective in suppressing the DTH response. TDH and Ts2 cells were mixed together and then adoptively transferred to naive recipient mice before and after treatment with anti-Lyt 2 antibody and complement. Control animals were adoptively given a mixture of TDH cells and normal spleen cells which were either untreated or treated with anti-Lyt 2 antibody and complement before transfer. The footpads of all groups of recipient mice plus a group of naive mice were challenged at the time of cell transfer. Footpad responses were measured 24 h later (Fig. 4) . LN and spleens of immunized mice contained TDH cells, and the addition of normal spleen cells did not abrogate the DTH response as indicated by the positive transfer of DTH (Fig. 4, groups 2 and 3, respectively) . When Ts2 cells were mixed with the same immune cell pools, the transfer of DTH was significantly inhibited (Fig. 4, groups 4 and 5). Treatment of the immune and normal spleen cell mixtures with anti-Lyt 2 antibody and complement did not affect the transfer of DTH (Fig. 4, groups 6 I.V. (Fig. 4) . These data demonstrate that Ts2 cell activity can be abrogated without affecting TDH cells when mixtures of TDH and Ts2 cells are treated with anti-Lyt 2 and complement; therefore, it can be assumed that DTH would have been effectively transferred in groups 4 and 5 ( Fig. 2 and 3 I.V, 130 Adoptive transfer of DTH with spleen cells (SPC) from mice which were immunized and given LN cells (LNC) from normal mice or which were immunized and given LNC from tolerized mice (Tsl). Specified LNC pools were treated with complement (C') alone or anti-Lyt 1.1, anti-Lyt 2.1, or anti-l-Jk antibody and C' before injection into donor mice. S.C., Subcutaneously; NS, not significant. of mice were transferred i.v. to naive syngeneic recipient groups of mice. The footpads of the recipient animals were challenged within 1 h of cell transfer. Final footpad measurements were made 24 h later (Fig. 5) . Similar results were obtained from the various groups of mice which had LN cells rather than spleen cells adoptively transferred (data not shown). As observed in earlier experiments, mice given normal LN cells at the time of immunization had spleen and LN cells which could adoptively transfer DTH responsiveness (Fig. 5, group 3) , whereas, mice given LN cells from tolerized mice did not produce sufficient numbers of TDH cells in either organ to adoptively transfer the response (Fig.  5, group 4) . When the Tsl-containing cell pools were treated with complement alone or with anti-Lyt 2.1 antibody and complement, they maintained the ability to suppress the induction of TDH cells (Fig. 5, groups 5 and 7, respectively) . However, when the Tsl cell pools were treated with anti-Lyt 1.1 or anti-IlJk antibody plus complement, they no longer suppressed the induction of TDH cells (Fig. 5, groups 6 and 8,  respectively) . These data show that the suppressor cells inhibiting TDH induction had the Lyt 1+ 2-, I-J+ phenotype of the cryptococcal Tsl cells. DISCUSSION From data generated in earlier studies, specific suppression of the cryptococcal DTH response appeared to be mediated by two different sets of suppressor cells, Tsl and Ts2 cells, functioning at two different stages in the response, i.e., the induction and expression phases, respectively (20) (21) (22) (20, 22) . Furthermore, it was established that the cells in the Tsl cell pools which were responsible for the apparent afferent suppression of the DTH response and induction of Ts2 cells were not only induced under the same conditions but were phenotypically the same with regard to the parameters assayed, i.e., Thy 1+, Lyt 1+ 2-, I-J+, and had cyclophosphamide-sensitive precursors (22) . It is possible that two different cell populations within the Tsl pools were mediating the two different observed effects; however, the available evidence does not support this idea but rather indicates that one cell type was responsible for the apparent afferent suppression and Ts2 cell induction (22) . Even if only one cell population is responsible for the observed effects, it is feasible that the two effects are the result of only one event not two. For example, Tsl cells may in fact not be suppressing the induction or afferent phase of the DTH response but rather inducing Ts2 cells which suppress the expression or efferent phase of the DTH response. The data presented in this paper, together with earlier studies (22) , support the contention that the cryptococcal Tsl cells play a dual role in the suppressive circuit, i.e., suppression of TDH cell induction and induction of Ts2 cells, rather than a single role, i.e., induction of Ts2 cells. Two different experimental approaches were taken to answer this question, and the data from both indicate that Tsl cells inhibit TDH cell induction.
First, the kinetic studies concerned with the effects of Tsl cells on induction of the DTH response suggested that Tsl cells inhibit TDH cell production (Fig. 1 ). This conclusion was drawn because Tsl cells were only effective in suppression of DTH when given at the time of immunization or within 1 day of immunization. Our previous unpublished studies indicated, under the conditions of immunization used in these experiments, that 3 days after immunization was the earliest time that significant levels of DTH could be detected by footpad challenge. Therefore, to effectively suppress, Tsl cells had to be in the system before or during the time TDH precursor cells were being stimulated by the immunizing dose of antigen. When Tsl cells were introduced into the system after TDH cells were generated (2 or more days postimmunization), suppression was not achieved (Fig. 1) The second experimental approach which involved demonstrating by adoptive transfer the presence or absence of TDH cells in mice suppressed by injection of either CneF antigen or Tsl cells confirmed that TDH cells were few to absent when Tsl cells were present at the time of immunization. The inability to transfer DTH from mice in which Tsl cells had been present at the time of immunization, along with the inability to reverse the negative transfers to positive transfers by eliminating any Ts2 cells which could have been present, supports the contention that TDH cell induction was inhibited by Tsl cells. However, there were two complicating factors which had to be eliminated before the previous conclusion could be considered valid. First, Ts2 cells mediate their effect via a soluble factor, TsF2 (21), which could have been released by treatment with anti-Lyt 2 antibody and complement. If TsF2 had bound to its target cells before the washings of the treated cells took place and if it bound tightly enough to resist removal by the washes, then reversal of negative transfers to positive transfers of DTH would not have occurred even when TDH cells were present. We demonstrated that such a scenario was not taking place by showing that mixtures of TDH and Ts2 cells did not tranfer DTH before treatment with anti-Lyt 2 and complement but did so after treatment (Fig. 4) . Second, cells other than Tsl cells in the LN cell populations from tolerized mice could have been responsible for suppression of TDH cell induction. This possibility was eliminated by demonstrating that suppression of TDH cell induction was abrogated when Tsl cells, which are Lyt 1+ 2-, I-J+, were removed from the suppressor cell-containing LN cell population (Fig. 5) . Taken together, the data presented ( Fig. 1 to 5 ) provide strong evidence which supports the hypothesis that Tsl cells suppress cryptococcal TDH cell induction. In addition, considering earlier data demonstrating that Tsl cells induce Ts2 cells (21, 22) , we favor the concept of a dual functional role for Tsl cells in the cryptococcal suppressor pathway.
Inhibition of induction of TDH cells is not unique to cryptococcal afferent suppressor cells. In the 2,4-dinitro-1-fluorobenzene suppressor cell model, it has been demonstrated that afferent Ts cells were effective in suppressing the DTH response only when they were present during early stages of the afferent phase of sensitization (18, 19) . Furthermore, the afferent suppressor cells specific to 2,4-dinitro-1-fluorobenzene were shown to inhibit antigen-induced cell proliferation (18, 19) , suggesting that TDH cell induction, including the proliferative aspect, was inhibited by the afferent Ts cells. However, in contrast to the cryptococcal suppressor cell pathway, as well as several other antigenspecific suppressor cell circuits (1, 7, 8, 24) , the suppressor cell sequence specific to 2,4-dinitro-1-fluorobenzene induced by 2,4-dinitrophenyl-coupled syngeneic LN cells has as its first-appearing suppressor cell an efferent suppressor that in turn induces a population of afferent suppressor cells (17) .
In addition to more specifically defining the role of the first-order suppressor cells in the cryptococcal model, this study demonstrated that the cryptococcal TDH cells were Lyt 2-, inferring that they were Lyt 1+ cells. Although it would be expected that cryptococcal TDH cells would be Lyt 1+ because that is the phenotype of other TDH cells, this is the first experimental documentation of the Lyt characteristics of the cryptococcal TDH cells.
